147 related articles for article (PubMed ID: 11423929)
1. Tissue-specific gene therapy directed to tumor angiogenesis.
Varda-Bloom N; Shaish A; Gonen A; Levanon K; Greenbereger S; Ferber S; Levkovitz H; Castel D; Goldberg I; Afek A; Kopolovitc Y; Harats D
Gene Ther; 2001 Jun; 8(11):819-27. PubMed ID: 11423929
[TBL] [Abstract][Full Text] [Related]
2. Specific induction of tumor neovasculature death by modified murine PPE-1 promoter armed with HSV-TK.
Varda-Bloom N; Hodish I; Shaish A; Greenberger S; Tal R; Feder B; Roitelman J; Breitbart E; Bangio L; Barshack I; Pfeffer R; Harats D
Pathobiology; 2008; 75(6):346-55. PubMed ID: 19096230
[TBL] [Abstract][Full Text] [Related]
3. Expression of thymidine kinase driven by an endothelial-specific promoter inhibits tumor growth of Lewis lung carcinoma cells in transgenic mice.
Dancer A; Julien S; Bouillot S; Pointu H; Vernet M; Huber P
Gene Ther; 2003 Jul; 10(14):1170-8. PubMed ID: 12833126
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
5. Systemic administration of a conditionally replicating adenovirus, targeted to angiogenesis, reduced lung metastases burden in cotton rats.
Peled M; Shaish A; Katav A; Greenberger S; Barshack I; Tal R; Bangio L; Breitbart E; Harats D
Clin Cancer Res; 2009 Mar; 15(5):1664-73. PubMed ID: 19240175
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific targeting using PSA promoter-based lentiviral vectors.
Yu D; Chen D; Chiu C; Razmazma B; Chow YH; Pang S
Cancer Gene Ther; 2001 Sep; 8(9):628-35. PubMed ID: 11593331
[TBL] [Abstract][Full Text] [Related]
7. Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice.
Jia S; Zhu F; Li H; He F; Xiu R
Clin Hemorheol Microcirc; 2000; 23(2-4):251-7. PubMed ID: 11321448
[TBL] [Abstract][Full Text] [Related]
8. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.
Mahasreshti PJ; Kataram M; Wang MH; Stockard CR; Grizzle WE; Carey D; Siegal GP; Haisma HJ; Alvarez RD; Curiel DT
Clin Cancer Res; 2003 Jul; 9(7):2701-10. PubMed ID: 12855650
[TBL] [Abstract][Full Text] [Related]
9. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell-based systemic gene therapy of metastatic melanoma.
Ojeifo JO; Lee HR; Rezza P; Su N; Zwiebel JA
Cancer Gene Ther; 2001 Sep; 8(9):636-48. PubMed ID: 11593332
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
Bequet-Romero M; Ayala M; Acevedo BE; Rodríguez EG; Ocejo OL; Torrens I; Gavilondo JV
Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
[TBL] [Abstract][Full Text] [Related]
13. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Yamamoto M; Alvarez RD; Curiel DT
Gene Ther; 2004 Apr; 11(7):645-8. PubMed ID: 15029227
[TBL] [Abstract][Full Text] [Related]
15. Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models.
Kishi Y; Kuba K; Nakamura T; Wen J; Suzuki Y; Mizuno S; Nukiwa T; Matsumoto K; Nakamura T
Cancer Sci; 2009 Jul; 100(7):1351-8. PubMed ID: 19438869
[TBL] [Abstract][Full Text] [Related]
16. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
17. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
18. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
[TBL] [Abstract][Full Text] [Related]
19. Transcription-controlled gene therapy against tumor angiogenesis.
Greenberger S; Shaish A; Varda-Bloom N; Levanon K; Breitbart E; Goldberg I; Barshack I; Hodish I; Yaacov N; Bangio L; Goncharov T; Wallach D; Harats D
J Clin Invest; 2004 Apr; 113(7):1017-24. PubMed ID: 15057308
[TBL] [Abstract][Full Text] [Related]
20. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.
Rubinchik S; Wang D; Yu H; Fan F; Luo M; Norris JS; Dong JY
Mol Ther; 2001 Nov; 4(5):416-26. PubMed ID: 11708878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
